The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Try the newly designed Company Pages!
Switch now

Pharmacyclics

  • PCYC
  • NASDAQ
  • Consumer Products
  • Latest 123.68
  • Currency US$
  • Change 2.36
  • Percent Change 1.945 %
  • Volume 715,590
  • Fri Oct 24, 2014 04:00 PM EDT NASDAQ data delayed 15 minutes.
  • Open 121.55
  • Previous Close 121.32
  • High 124.19
  • Low 120.53
  • Bidx0 0.0000
  • Askx0 0.0000
  • 52-week High02/21 154.89
  • 52-week Low05/27 82.51
  • Beta 1.359
  • Market Cap 9,250.03M
  • EPS 1.11
  • P/E 111.423
  • Forward P/E 268.87
  • PEG
  • Annual Dividend 0.0000
  • Yield

News

Financials & Calendars

Income Statement

  • Sales $376,700,000
  • Earnings $137,190,000
  • Return on Equity 21.24%

Cash Flow

  • Cash Flow --
  • Cash $678,620,000
  • Current Ratio 8.12

12 months ended Mar 31, 2014.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $805,760,000
  • Liabilities $141,380,000
  • Liabilities-to-Equity Ratio 0.21

Price Ratios

  • Price to Sales 24.56
  • Price to Book 13.92
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Jul 31 $-0.20 Nov 6 $0.37
Surprises Jul 31 145.00% n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Oct 25, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Pharmacyclics Inc. is a pharmaceutical company developing products to improve upon therapeutic approaches to cancer, atherosclerosis and retinal disease. The company's products are ring-shaped small molecules called texaphyrins. These patented agents are derived from Pharmacyclics' versatile technology platform for designing and synthesizing energy-potentiating drugs. The texaphyrins localize in cancer cells, atherosclerotic plaque and neovasculature, where they can be activated by forms of energy, including X-rays and light to reduce diseased tissue.

Related Securities
Symbol Type Latest % Chg

Officers

  • Robert W. Duggan Chairman of the Board & C.E.O
  • Manmeet Soni Chief Financial Officer
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

PHARMACYCLICS INC 995 E ARQUES
SUNNYVALE, CA
94085-4

Phone: (408)-774-0330
Fax: (408)-7740340


www.pharmacyclics.com

Ideas & Discussion

Live Discussion of PCYC on StockTwits
The Globe and Mail has
updated our Company Pages
Switch to the newly designed Company Pages format today for a more in-depth look at the companies you're following and pages that are easier to navigate. If you prefer the old layout after trying the new Company Pages, you can switch back anytime.